Perrigo

PRGO · NYSE · Healthcare · United States

$10.53+0.5%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:28 PM

Financials at a glance

Source: SEC XBRL

Annual

FY2023FY2024FY2025$4.7B$4.7B$4.4B$4.4B$4.3B$4.3B-33.5% margin-33.5% marginRevenueNet margin

Quarterly · last 8

Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26$1.1B$1.1B$1.1B$1.1B$1.1B$1.1B$1.1B$1.1B$1.0B$1.0B$1.1B$1.1B$1.0B$1.0B$969.2M$969.2M-41.1% margin-41.1% marginRevenueNet margin

Market cap

$1.5B

Day change

+0.5%

Fwd P/E

4.5

P/B

0.6

Div yield

11.08%

Beta

0.52

Revenue (FY2025)

$4.3B

Net margin

-33.5%

ROE

-48.6%

Revenue CAGR (2y)

-4.4%

EPS (FY2025)

-10.29

Net profit (FY2025)

$-1.4B

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about PRGO

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

PeriodRevenueNet profitEPSNet marginROE
FY2025$4.3B$-1.4B-10.29-33.5%-48.6%
FY2024$4.4B$-171.8M-1.25-3.9%-4.0%
FY2023$4.7B$-12.7M-0.09-0.3%-0.3%

Quarterly

PeriodRevenueNet profitEPSNet margin
2026Q1$969.2M$-398.6M-2.87-41.1%
2025Q3$1.0B$7.5M0.050.7%
2025Q2$1.1B$-8.4M-0.06-0.8%
2025Q1$1.0B$-6.4M-0.05-0.6%
2024Q3$1.1B$-21.0M-0.15-1.9%
2024Q2$1.1B$-108.4M-0.79-10.2%
2024Q1$1.1B$2.0M0.010.2%
2023Q3$1.1B$8.4M0.100.7%
2023Q2$1.2B$-3.0M-0.02-0.3%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.